ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,665,000 | +41525.0% | 910,000 | +45196.2% | 0.00% | – |
| Q1 2021 | $4,000 | -81.8% | 2,009 | -80.6% | 0.00% | – |
| Q4 2020 | $22,000 | +214.3% | 10,338 | +270.5% | 0.00% | – |
| Q3 2020 | $7,000 | -98.5% | 2,790 | -98.2% | 0.00% | – |
| Q2 2020 | $455,000 | +18.8% | 158,821 | +7.5% | 0.00% | – |
| Q1 2020 | $383,000 | -33.5% | 147,803 | +2.5% | 0.00% | – |
| Q4 2019 | $576,000 | +2780.0% | 144,137 | +3164.7% | 0.00% | – |
| Q3 2019 | $20,000 | +122.2% | 4,415 | +89.5% | 0.00% | – |
| Q2 2019 | $9,000 | – | 2,330 | +19316.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 12 | -95.7% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 279 | +108.2% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |